<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for BIO</title>
    <link />
    <description>Headlines for Bio-Rad Laboratories, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Earnings Miss at SurModics - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98973/earnings-miss-at-surmodics.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 08 May 2013 17:39:01 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad Laboratories Whiffs on Earnings</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/08/bio-rad-laboratories-whiffs-on-earnings/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 08 May 2013 17:08:50 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1412011-bio-rad-laboratories-management-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 21:40:07 GMT</pubDate>
    </item>
    <item>
      <title>Covance Inc. (CVD): Today's Most Compelling Stock Buy</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/covance-inc-cvd-todays-most-compelling-stock-buy-cm243860.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 06 May 2013 11:48:33 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Bio-Rad Laboratories on 4Q12 Non-GAAP EPS</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/02/3373152/update-jefferies-reiterates-buy-rating-raises-pt-on-bio-.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 27 Feb 2013 11:52:40 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad Laboratories Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1227561-bio-rad-laboratories-management-discusses-q4-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 26 Feb 2013 21:10:17 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad Laboratories Outruns Estimates Again</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/26/bio-rad-laboratories-outruns-estimates-again/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 26 Feb 2013 20:50:07 GMT</pubDate>
    </item>
    <item>
      <title>After-Hours Earnings Report for February 26, 2013 :  PCLN, VNO, EIX, RRC, WFT, VRSK, AVGO, AWK, ERIE</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/afterhours-earnings-report-for-february-26-2013-pcln-vno-eix-rrc-wft-vrsk-avgo-awk-erie-jazz-fslr-bio-cm221343.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 26 Feb 2013 14:00:04 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad Laboratories Earnings Are on Deck</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/25/bio-rad-laboratories-earnings-are-on-deck/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 25 Feb 2013 01:26:15 GMT</pubDate>
    </item>
    <item>
      <title>Downside From Davos - It's A Riskier World Than 2012 - How To Benefit</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1144461-downside-from-davos-it-s-a-riskier-world-than-2012-how-to-benefit.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 30 Jan 2013 15:33:26 GMT</pubDate>
    </item>
    <item>
      <title>Why Harvard Bioscience Is Poised to Pop</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/22/why-harvard-bioscience-is-poised-to-pop/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 22 Jan 2013 18:21:00 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad Labs Buys AbD Serotec for €53M</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3231978/bio-rad-labs-buys-abd-serotec-for-53m.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 10 Jan 2013 09:07:35 GMT</pubDate>
    </item>
    <item>
      <title>Here's Why Bio-Rad Laboratories's Latest Report Might Worry You</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/18/heres-why-bio-rad-laboratoriess-latest-report-mig/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 18 Dec 2012 09:02:09 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad to Buy Germany's AbD Serotec for $70 Million</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/17/news-bio-rad-to-buy-abd-serotec-for-70-million/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 17 Dec 2012 18:12:02 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad to Buy AbD Serotec - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/88703/bio-rad-to-buy-abd-serotec.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 17 Dec 2012 12:00:01 GMT</pubDate>
    </item>
    <item>
      <title>This Metric Says You're Smart to Own Bio-Rad Laboratories</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/27/this-metric-says-youre-smart-to-own-bio-rad-labor/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 27 Nov 2012 01:05:38 GMT</pubDate>
    </item>
    <item>
      <title>TEXT-Fitch affirms Bio-Rad's ratings at 'BBB-'</title>
      <link>http://www.fool.com/news/xt/reuters/www.reuters.com/article/marketsnews/iduswna949620121114.aspx</link>
      <author>Reuters</author>
      <pubDate>Wed, 14 Nov 2012 10:07:29 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad Laboratories Crushes Earnings Estimates</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/07/bio-rad-laboratories-crushes-earnings-estimates/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 07 Nov 2012 13:03:50 GMT</pubDate>
    </item>
    <item>
      <title>Bio-Rad Laboratories Management Discusses Q3 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/984801-bio-rad-laboratories-management-discusses-q3-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 06 Nov 2012 19:20:07 GMT</pubDate>
    </item>
    <item>
      <title>Earnings Analysis For Pall Corp.: Sustainable Returns Relative To Peers</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/868411-earnings-analysis-for-pall-corp-sustainable-returns-relative-to-peers.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 14 Sep 2012 15:28:05 GMT</pubDate>
    </item>
  </channel>
</rss>
